Inhibitors for proliferating cell nuclear antigen and uses
Abstract:
The present invention relates to series of compounds as an inhibitor targeting Proliferating Cell Nuclear Antigen (PCNA). Pharmaceutical compositions of those compounds and methods of using them in the treatment of cancer are within the scope of this disclosure.
Public/Granted literature
Information query
Patent Agency Ranking
0/0